AIP Human

Aryl Hydrocarbon Receptor Interacting Protein Human Recombinant
Shipped with Ice Packs
In Stock

Description

Functional Roles and Interactions

AIP operates through three primary mechanisms:

  1. AhR signaling regulation: Enhances ligand receptivity and nuclear targeting of the aryl hydrocarbon receptor

  2. Chaperone activity: Forms complexes with Hsp90 to stabilize client proteins like AhR and peroxisome proliferator-activated receptor alpha

  3. Tumor suppression: Reduces cell proliferation via interactions with RET proto-oncogene and phosphodiesterase PDE4A5

Notably, AIP co-localizes with growth hormone (GH) in somatotroph secretory vesicles but circulates independently of GH under basal or stimulated conditions .

Clinical and Research Findings (Table 2)

Study FocusKey ResultsSource
Circulating AIP levelsNo correlation with age, sex, BMI, or glucose levels; GH-independent secretion
AIP mutations in FIPA15-40% of familial isolated pituitary adenoma cases; mean diagnosis age 23.6 years
Recombinant AIP stabilityMaintains activity in 20 mM Tris-HCl (pH 8.0) with 1 mM DTT and 10% glycerol

Disease Associations

AIP dysfunction is linked to:

  • Familial pituitary adenomas: 20% of mutation carriers develop growth hormone-secreting tumors by age 30

  • Acromegaly: 50% of AIP mutation-associated adenomas show GH hypersecretion

  • Antiviral response suppression: Interaction with IRF7 inhibits type I interferon production

Recombinant AIP Applications

The human recombinant form (PRO-886) serves as a critical tool for:

  • Studying AhR-mediated toxin responses

  • Analyzing tumor suppressor mechanisms in in vitro models

  • Developing diagnostic assays for AIP-related endocrine disorders

Product Specs

Introduction
The aryl hydrocarbon receptor (AHR) interacting protein (AIP) may play a positive role in AHR-mediated signaling, potentially by influencing the receptor's ability to bind ligands or its transportation to the nucleus. AIP acts as a cellular negative regulator of the hepatitis B virus (HBV) X protein. Additionally, AIP is found throughout the body and binds to HSP 90 and AHR through a highly conserved carboxy-terminal tetratricopeptide repeat domain.
Description
Recombinant human AIP, produced in E. coli, is a single, non-glycosylated polypeptide chain consisting of 350 amino acids (residues 1-330) with a molecular weight of 39.8 kDa. The AIP protein is fused to a 20 amino acid His-tag at the N-terminus and purified using proprietary chromatographic techniques.
Physical Appearance
A clear solution that has undergone sterile filtration.
Formulation
The AIP protein solution has a concentration of 1 mg/ml and contains 20 mM Tris-HCl buffer (pH 8.0), 1 mM DTT, and 10% glycerol.
Stability
For short-term storage (2-4 weeks), keep the vial at 4°C. For extended periods, store the protein frozen at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeatedly freezing and thawing the protein.
Purity
Purity is greater than 90.0% as determined by SDS-PAGE analysis.
Synonyms

AH receptor-interacting protein, AIP, Aryl-hydrocarbon receptor-interacting protein, HBV X-associated protein 2, XAP-2, Immunophilin homolog ARA9, XAP2, ARA9, FKBP16, FKBP37, SMTPHN.

Source
Escherichia Coli.
Amino Acid Sequence

MGSSHHHHHH SSGLVPRGSH MADIIARLRE DGIQKRVIQE GRGELPDFQD GTKATFHYRT LHSDDEGTVL DDSRARGKPM ELIIGKKFKL PVWETIVCTM REGEIAQFLC DIKHVVLYPL VAKSLRNIAV GKDPLEGQRH CCGVAQMREH SSLGHADLDA LQQNPQPLIF HMEMLKVESP
GTYQQDPWAM TDEEKAKAVP LIHQEGNRLY REGHVKEAAA KYYDAIACLK NLQMKEQPGS PEWIQLDKQI TPLLLNYCQC KLVVEEYYEV LDHCSSILNK YDDNVKAYFK RGKAHAAVWN AQEAQADFAK VLELDPALAP VVSRELRALE ARIRQKDEED KARFRGIFSH.

Q&A

What is the biological mechanism of AIP and how is it typically studied?

AIP is a genetic disorder caused by a partial deficiency of the enzyme porphobilinogen deaminase (PBGD), also known as hydroxymethylbilane synthase (HMBS). This enzyme plays a critical role in heme production, and its deficiency leads to the accumulation of precursor molecules that can cause AIP attacks. Research methodologies typically include enzyme activity assays, genetic sequencing of the HMBS gene, and biochemical analysis of porphyrin precursors in urine and blood. Experimental models employ both cell culture systems with HMBS mutations and transgenic animal models to study the pathophysiological mechanisms of AIP .

How do researchers distinguish between overt and latent AIP in study populations?

Researchers employ multiple methodological approaches to differentiate between overt AIP (symptomatic) and latent AIP (asymptomatic carriers). The primary distinction involves:

  • Clinical history assessment: Documentation of previous acute attacks with characteristic symptoms

  • Biochemical markers: Quantification of urinary porphobilinogen (PBG) levels, which are significantly elevated during attacks

  • Genetic testing: Identification of HMBS gene mutations

  • Challenge tests: In some research protocols, controlled administration of potential triggers under medical supervision

For research cohort stratification, individuals with documented attacks are classified as having overt AIP, while those with confirmed HMBS mutations but no clinical manifestations are classified as having latent AIP .

What methodological challenges exist in AIP trigger research?

Investigating AIP triggers presents several methodological challenges:

  • Temporal relationship complexity: Multiple simultaneous triggers often precede attacks, making causality difficult to establish

  • Individual variability: The threshold for triggering varies significantly between patients

  • Ethical limitations: Deliberate provocation testing is generally contraindicated due to potential harm

  • Retrospective bias: Patient recall of pre-attack circumstances may be unreliable

Researchers address these challenges through prospective diary studies, biomarker monitoring (urinary PBG measurements), and case-control studies comparing environmental exposures and medication use during attack and non-attack periods .

What methodological approaches are used to study familial inheritance patterns in AIP?

Research methodologies for studying AIP inheritance include:

Pedigree analysis: Documenting the autosomal dominant inheritance pattern where offspring have a 50% chance of inheriting the mutation when one parent carries the mutation.

Genetic sequencing: Identifying specific HMBS gene mutations, which can vary between families.

Penetrance studies: Investigating why most individuals with mutations remain asymptomatic (latent AIP), focusing on genetic modifiers and environmental factors.

Genotype-phenotype correlation: Examining whether specific mutations correlate with clinical severity or attack frequency .

What is the regulatory framework for AIP in human subjects research?

Approval-In-Principle (AIP) is a regulatory mechanism established under 45 CFR 46.118 to facilitate review of research proposals that lack definite plans for human subject involvement at the time of application. This framework is specifically designed for studies where human participation will occur in later phases contingent upon preliminary development activities. AIPs function as a provisional approval that acknowledges the eventual human subjects component while recognizing that detailed protocols cannot yet be formulated .

What activities can and cannot be conducted under an AIP approval?

Under AIP approval, researchers may conduct:

  • Development of research instruments and survey tools

  • Refinement of experimental compounds

  • Preliminary animal studies

  • Creation of study protocols and statistical analysis plans

  • Establishment of laboratory procedures

Prohibited activities under AIP include:

  • Any direct human subjects recruitment

  • Obtaining informed consent

  • Research interactions or interventions with human participants

  • Collection of human biological samples

  • Analysis of identifiable private information

  • Pilot testing with human subjects

An AIP serves as a framework for preliminary research activities that must be completed before human subjects involvement can be appropriately designed and implemented .

What methodological steps are involved in transitioning from an AIP to full IRB approval?

The methodological progression from AIP to full IRB approval involves:

  • Completion of developmental phase: Document all preliminary work conducted under the AIP

  • Protocol finalization: Develop detailed research procedures based on preliminary findings

  • Risk assessment: Evaluate potential risks to participants based on finalized methods

  • IRB submission: Prepare comprehensive documentation including:

    • Detailed study protocol

    • Informed consent documents

    • Recruitment materials

    • Data safety monitoring plans

    • Instruments and measures

  • Regulatory response: Address IRB questions and concerns

  • Approval implementation: Transition from developmental to active human research

This transition requires explicit documentation of how preliminary work informed the final protocol design and how any potential risks identified during development will be mitigated .

What neuroimaging techniques are most effective for localizing human AIP?

Research on the anterior intraparietal area (AIP) employs multiple neuroimaging approaches, with functional magnetic resonance imaging (fMRI) being the predominant method. Task-based fMRI using visually guided hand movement paradigms and 3D object discrimination tasks has effectively localized AIP. Researchers typically employ:

  • Block design protocols: Alternating periods of AIP-targeted tasks with control conditions

  • Event-related designs: Isolating specific cognitive components of grasping or object recognition

  • Retinotopic mapping: Establishing relationships to nearby visual processing regions

  • Multimodal approaches: Combining fMRI with MEG or EEG for temporal precision

Reliable anatomical landmarks place human AIP at the junction of the anterior intraparietal sulcus and the postcentral sulcus, with subject-level localization being crucial due to individual anatomical variability .

How do researchers differentiate between AIP, CIP, and LIP in imaging studies?

Differentiating between anterior (AIP), caudal (CIP), and lateral (LIP) intraparietal areas requires precise methodological approaches:

AreaPrimary FunctionTask ParadigmAnatomical Landmark
AIPVisually guided hand movements, graspingObject manipulation, 3D feature processingRostral part of lateral bank of anterior IPS
CIPSurface orientation processing, depth perceptionSurface orientation discriminationMedial side branch of posterior IPS
LIPSaccadic eye movements, spatial attentionMemory-guided saccades, spatial working memoryMiddle region of IPS

Researchers employ differential task activation patterns to distinguish these functionally specialized regions. For example, studies use delayed matching-to-sample tasks with orientation judgments to activate CIP, while memory-guided saccadic eye movement tasks activate LIP. Eye movement recording during scanning ensures task compliance and helps differentiate activation related to hand movements from that related to eye movements .

What methodological challenges exist in translating non-human primate AIP findings to humans?

Translating AIP research from non-human primates to humans presents several methodological challenges:

  • Anatomical differences: Human IPS shows greater complexity and individual variability compared to non-human primates

  • Functional homology uncertainty: While functionally similar, human and non-human primate AIP may not be perfectly homologous

  • Experimental design constraints: Tasks optimized for non-human primates often require modification for human participants

  • Resolution limitations: Single-unit recordings in non-human primates provide cellular-level data unavailable in typical human studies

Research groups address these challenges through:

  • Conducting parallel experiments with matched task designs

  • Employing high-field MRI for improved spatial resolution

  • Using multivariate pattern analysis to detect fine-grained activation patterns

  • Developing naturalistic tasks that can be performed similarly by both humans and non-human primates

What evidence supports functional specialization within the human AIP?

Current research indicates functional specialization within human AIP for processing different aspects of object-directed actions:

  • Ventral-dorsal organization: Ventral regions primarily process object properties (shape, size), while dorsal regions process action parameters (grip type, force)

  • Temporal dynamics: Early activation relates to object recognition, while later activation relates to motor planning

  • Connectivity patterns: Different AIP subregions show preferential connectivity with either ventral visual areas or motor planning regions

Studies employing high-resolution fMRI have revealed that AIP activation is not homogeneous but shows task-specific patterns. For example, discrimination of object orientation engages different AIP subregions than grasping movements directed toward the same objects. This functional organization appears to support the transformation of visual information into appropriate hand configurations for object interaction .

What methodological approaches facilitate interdisciplinary AIP research?

Interdisciplinary AIP research requires methodological frameworks that bridge different research domains:

  • Standardized terminology: Developing clear terminology distinguishing AIP contexts to avoid confusion in literature searches and citations

  • Cross-domain collaborative teams: Involving experts from genetics, neuroscience, and clinical medicine in research design

  • Comprehensive protocol design: Accounting for potential confounding variables across domains

  • Integrated data management: Creating systems that accommodate diverse data types from various methodological approaches

Successful interdisciplinary studies typically employ mixed-methods approaches that integrate quantitative measurements with qualitative insights from different disciplinary perspectives .

How should researchers approach ethical considerations in different AIP contexts?

Ethical considerations vary significantly across AIP contexts:

For Acute Intermittent Porphyria studies:

  • Genetic privacy and implications for family members

  • Risk management during research participation

  • Access to emergency treatments during studies

For Approval-In-Principle human research:

  • Maintaining clear boundaries before human subjects involvement

  • Ensuring preparedness for ethical human subjects research

  • Transparent communication with regulatory bodies

For Anterior Intraparietal Area neuroscience research:

  • Balancing task complexity with participant comfort

  • Managing incidental neurological findings

  • Ensuring data privacy in brain imaging repositories

Researchers should develop context-specific ethical frameworks while adhering to core principles of autonomy, beneficence, non-maleficence, and justice across all AIP domains .

What emerging methodologies are advancing AIP research?

Across all AIP contexts, technological and methodological innovations are advancing research capabilities:

For Acute Intermittent Porphyria:

  • Gene editing approaches for potential therapeutic applications

  • Longitudinal biomarker studies using wearable monitoring technology

  • Systems biology approaches integrating metabolomic and genomic data

For Approval-In-Principle processes:

  • Digital tracking systems for developmental research phases

  • Harmonized international regulatory frameworks

  • Adaptive protocol designs that evolve from AIP to full IRB approval

For Anterior Intraparietal Area neuroscience:

  • Ultra-high field neuroimaging (7T and higher)

  • Combined TMS-fMRI approaches for causality assessment

  • Computational modeling of AIP networks in sensorimotor control

These emerging methodologies promise to address current research limitations while opening new avenues for investigation across all AIP domains .

How might researchers address current contradictions in AIP literature?

Researchers should employ systematic approaches to resolve contradictions:

  • Meta-analytic techniques: Quantitatively synthesizing existing literature to identify moderating variables explaining inconsistent findings

  • Multi-site collaboration: Implementing standardized protocols across research centers to increase sample size and generalizability

  • Pre-registration: Documenting hypotheses and analysis plans before data collection to reduce publication bias

  • Replication focus: Prioritizing direct replication of key findings before extending to new hypotheses

  • Open science practices: Sharing data, materials, and analysis code to enable verification and alternative analyses

Product Science Overview

Introduction

Aryl Hydrocarbon Receptor Interacting Protein (AIP) is a crucial molecular chaperone that plays a significant role in the regulation of the Aryl Hydrocarbon Receptor (AhR) signaling pathway. This pathway is involved in various biological processes, including xenobiotic metabolism, immune response, and cell proliferation. AIP is particularly important in maintaining the stability and proper functioning of AhR, which is a ligand-activated transcription factor.

Structure and Function

AIP is a protein composed of 330 amino acids and is encoded by the AIP gene located on chromosome 11q13.3. The protein contains several functional domains, including a tetratricopeptide repeat (TPR) domain, which is essential for protein-protein interactions. The TPR domain allows AIP to interact with various client proteins, including AhR, heat shock proteins (HSP90), and other co-chaperones.

The primary function of AIP is to facilitate the proper folding and stabilization of AhR. In the absence of a ligand, AhR resides in the cytoplasm in a complex with AIP, HSP90, and other co-chaperones. Upon ligand binding, AhR undergoes a conformational change, dissociates from the complex, and translocates to the nucleus, where it dimerizes with the Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT). This complex then binds to xenobiotic response elements (XREs) in the DNA, leading to the transcription of target genes involved in xenobiotic metabolism and other cellular processes .

Biological Significance

AIP has been implicated in various physiological and pathological processes. It plays a critical role in the immune system by modulating the activity of AhR, which influences the differentiation and function of immune cells. Additionally, AIP is involved in the regulation of cell proliferation and apoptosis, making it a key player in cancer biology.

Recent studies have shown that AIP is overexpressed in certain types of cancer, such as colorectal cancer, and is associated with poor prognosis. AIP overexpression has been linked to increased tumorigenic and metastatic properties, particularly in highly metastatic colorectal cancer cells. This suggests that AIP may serve as a potential therapeutic target for cancer treatment .

Recombinant AIP

Recombinant AIP is produced using recombinant DNA technology, which involves the insertion of the AIP gene into an expression vector, followed by the expression of the protein in a suitable host system, such as Escherichia coli or mammalian cells. The recombinant protein is then purified using various chromatographic techniques to obtain a highly pure and biologically active form of AIP.

Recombinant AIP is widely used in research to study the molecular mechanisms of AhR signaling and its role in various biological processes. It is also used in drug discovery and development to screen for potential modulators of the AhR pathway.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.